These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21699081)

  • 41. Gas chromatographic-mass spectrometric fragmentation study of flavonoids as their trimethylsilyl derivatives: analysis of flavonoids, sugars, carboxylic and amino acids in model systems and in citrus fruits.
    Füzfai Z; Molnár-Perl I
    J Chromatogr A; 2007 May; 1149(1):88-101. PubMed ID: 17289064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pro-oxidative effect of beta-carotene and the interaction with flavonoids on UVA-induced DNA strand breaks in mouse fibroblast C3H10T1/2 cells.
    Yeh SL; Wang WY; Huang CH; Hu ML
    J Nutr Biochem; 2005 Dec; 16(12):729-35. PubMed ID: 16098732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
    Piao YJ; Choi JS
    J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
    Zhang S; Sagawa K; Arnold RD; Tseng E; Wang X; Morris ME
    J Pharm Sci; 2010 Jan; 99(1):430-41. PubMed ID: 19499569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female rats.
    Vaidyanathan S; Boroujerdi M
    Cancer Chemother Pharmacol; 2000; 46(3):185-92. PubMed ID: 11021735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
    Pingili RB; Pawar AK; Challa SR
    Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats.
    Mandadi K; Ramirez M; Jayaprakasha GK; Faraji B; Lihono M; Deyhim F; Patil BS
    Phytomedicine; 2009 Jun; 16(6-7):513-20. PubMed ID: 18930642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
    Planting AS; Sonneveld P; van der Gaast A; Sparreboom A; van der Burg ME; Luyten GP; de Leeuw K; de Boer-Dennert M; Wissel PS; Jewell RC; Paul EM; Purvis NB; Verweij J
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):91-9. PubMed ID: 15565444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?
    Ofer M; Wolffram S; Koggel A; Spahn-Langguth H; Langguth P
    Eur J Pharm Sci; 2005 Jun; 25(2-3):263-71. PubMed ID: 15911222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [UPLC-Q-TOF-MS analysis of naringin and naringenin and its metabolites in rat plasma after intragastrical administration of alcohol extract of exocarpium Citri grandis].
    Sun G; Qian D; Duan J; Li X; Wan J; Guo J
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(12):1580-5. PubMed ID: 20815212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin.
    Binkhathlan Z; Shayeganpour A; Brocks DR; Lavasanifar A
    Eur J Pharm Biopharm; 2012 May; 81(1):142-8. PubMed ID: 22361031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mass spectrometric identification and high-performance liquid chromatographic determination of a flavonoid glycoside naringin in human urine.
    Ishii K; Furuta T; Kasuya Y
    J Agric Food Chem; 2000 Jan; 48(1):56-9. PubMed ID: 10637051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Life Sci; 2008 Aug; 83(7-8):250-9. PubMed ID: 18619980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats.
    Pingili R; Vemulapalli S; Mullapudi SS; Nuthakki S; Pendyala S; Kilaru N
    Drug Dev Ind Pharm; 2016; 42(7):1110-7. PubMed ID: 26530401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats.
    Lim SC; Choi JS
    Biopharm Drug Dispos; 2006 Dec; 27(9):443-7. PubMed ID: 17009338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man.
    Lee YS; Reidenberg MM
    Pharmacology; 1998 Jun; 56(6):314-7. PubMed ID: 9654218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of anticancer drug-induced P-glycoprotein expression by naringin.
    Ali MM; Agha FG; El-Sammad NM; Hassan SK
    Z Naturforsch C J Biosci; 2009; 64(1-2):109-16. PubMed ID: 19323275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish.
    Burkina V; Zlabek V; Halsne R; Ropstad E; Zamaratskaia G
    Biochem Pharmacol; 2016 Jun; 110-111():109-16. PubMed ID: 27107807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.